International Journal of Molecular Sciences · 2022 · 13 citations · 30 references
Life SciencesNeurobiologyNeuroscienceDementiaNeurobiology Of DiseaseNeurodegenerationAlzheimer DiseaseGlial PathologyLipid MetabolismNeurodegenerative DiseasesNeurodegenerative DisordersReactive GliosisAlzheimer Disease ProgressionAlzheimer's Disease ModelsAmyloid Beta PlaquesAmyloid PlaquesHigh-density Lipoprotein MetabolismLipid Metabolism AlterationsLow-density Lipoprotein ParticlesPathological Correlates
The typical pathological features of Alzheimer's disease (AD) are the accumulation of amyloid plaques in the brain and reactivity of glial cells such as astrocytes and microglia. Clinically, the development of AD and obesity are known to be correlated. In this study, we analyzed the changes in AD pathological characteristics in 5XFAD mice after obesity induction through a high-fat diet (HFD). Surprisingly, high-density lipoprotein and apolipoprotein AI (APOA-I) serum levels were increased without low-density lipoprotein alteration in both HFD groups. The reactivity of astrocytes and microglia in the dentate gyrus of the hippocampus and fornix of the hypothalamus in 5XFAD mice was decreased in the transgenic (TG)-HFD high group. Finally, the accumulation of amyloid plaques in the dentate gyrus region of the hippocampus was also significantly decreased in the TG-HFD high group. These results suggest that increased high-density lipoprotein level, especially with increased APOA-I serum level, alleviates the pathological features of AD and could be a new potential therapeutic strategy for AD treatment.
30
An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease
Deborah Gustafson, Elisabet Rothenberg, Kaj Blennow et al. · Archives of Internal Medicine · 2003 · 805 citations
Midlife and Late-Life Obesity and the Risk of Dementia
Annette L. Fitzpatrick, Lewis H. Kuller, Oscar L. López et al. · Archives of Neurology · 2009 · 783 citations · Full text